EU-Commission establishs HERA Incubator
EU-Commission has proposed an European bio-defence preparedness plan against COVID-19 variants, the so called “HERA Incubator”.
With this immediate action Europe shall be prepared for the increased threat of coronavirus variants. Within the HERA Incubator researchers, biotech companies, manufacturers and public authorities in the EU and globally will work together to detect new variants, provide incentives to develop new and adapted vaccines, speed up the approval process for these vaccines, and ensure scaling up of manufacturing capacities.
Further information concerning the key actions and the press release from 17.02.2021 you may find here.